|
Video: What is a Stock Split?
|
|
TRxADE Health operates a business-to-business web-based marketplace focused on the pharmaceutical industry. Co.'s products and services include: Trxade.com, which is a web-based pharmaceutical marketplace engaged in promoting commerce among independent pharmacies and pharmaceutical suppliers; Delivmeds.com., which provides delivery of pharmaceutical products associated with Co.'s subsidiary, Alliance Pharma Solutions, LLC.; Trxade Prime, which allows pharmacy members on the Trxade platform to process and ship purchase orders; and MedCheks Health Passport, which is a precision healthcare platform that lets patients control their health data via a digital Health Passport. According to our MEDS split history records, TRxADE Health has had 2 splits. | |
|
TRxADE Health (MEDS) has 2 splits in our MEDS split history database. The first split for MEDS took place on August 11, 2008. This was a 1 for 25 reverse split, meaning for each 25 shares of MEDS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split. MEDS's second split took place on June 22, 2023. This was a 1 for 15 reverse split, meaning for each 15 shares of MEDS owned pre-split, the shareholder now owned 1 share. For example, a 40 share position pre-split, became a 2.66666666666667 share position following the split.
When a company such as TRxADE Health conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the MEDS split history from start to finish, an original position size of 1000 shares would have turned into 2.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TRxADE Health shares, starting with a $10,000 purchase of MEDS, presented on a split-history-adjusted basis factoring in the complete MEDS split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$22.50 |
|
End price/share: |
$10.24 |
|
Starting shares: |
444.44 |
|
Ending shares: |
818.32 |
|
Dividends reinvested/share: |
$8.00 |
|
Total return: |
-16.20% |
|
Average Annual Total Return: |
-1.75% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,381.98 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$22.50 |
|
End price/share: |
$10.24 |
|
Dividends collected/share: |
$8.00 |
|
Total return: |
-18.93% |
|
Average Annual Total Return: |
-2.08% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,104.74 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
08/11/2008 | 1 for 25 | 06/22/2023 | 1 for 15 |
|
|